Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aviptadil”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT04844580
What this trial is testing

A Clinical Study Evaluating Inhaled Aviptadil on COVID-19

Who this might be right for
Covid19
Centurion Pharma 80
Testing effectiveness (Phase 2)Ended earlyNCT04536350
What this trial is testing

Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Who this might be right for
Covid19Corona Virus InfectionARDS+1 more
Prof. Dr. Jörg Leuppi 83
Large-scale testing (Phase 3)Ended earlyNCT04360096
What this trial is testing

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Who this might be right for
SARS-CoV 2COVIDARDS+3 more
APR Applied Pharma Research s.a. 144
Not applicableNo Longer AvailableNCT04453839
What this trial is testing

ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)

Who this might be right for
Critical COVID-19 With Respiratory Failure
APR Applied Pharma Research s.a.
Large-scale testing (Phase 3)Study completedNCT04311697
What this trial is testing

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

Who this might be right for
Critical COVID-19 With Respiratory FailureAcute Respiratory Distress Syndrome (ARDS)Corona Virus Infection+1 more
APR Applied Pharma Research s.a. 203
Large-scale testing (Phase 3)Study completedNCT06729606
What this trial is testing

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 471
Large-scale testing (Phase 3)WithdrawnNCT05137795
What this trial is testing

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

Who this might be right for
SARS-CoV 2COVIDARDS+3 more
APR Applied Pharma Research s.a.